BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25879302)

  • 1. The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis.
    Mikula P; Nagyova I; Krokavcova M; Vitkova M; Rosenberger J; Szilasiova J; Gdovinova Z; Groothoff JW; van Dijk JP
    Psychol Health Med; 2015; 20(6):653-61. PubMed ID: 25879302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spiroergometric and spirometric parameters in patients with multiple sclerosis: are there any links between these parameters and fatigue, depression, neurological impairment, disability, handicap and quality of life in multiple sclerosis?
    Rasova K; Brandejsky P; Havrdova E; Zalisova M; Rexova P
    Mult Scler; 2005 Apr; 11(2):213-21. PubMed ID: 15794397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors.
    Trojan DA; Arnold D; Collet JP; Shapiro S; Bar-Or A; Robinson A; Le Cruguel JP; Ducruet T; Narayanan S; Arcelin K; Wong AN; Tartaglia MC; Lapierre Y; Caramanos Z; Da Costa D
    Mult Scler; 2007 Sep; 13(8):985-95. PubMed ID: 17468448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
    Dalgas U; Stenager E; Jakobsen J; Petersen T; Hansen HJ; Knudsen C; Overgaard K; Ingemann-Hansen T
    Mult Scler; 2010 Apr; 16(4):480-90. PubMed ID: 20194584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coping and its importance for quality of life in patients with multiple sclerosis.
    Mikula P; Nagyova I; Krokavcova M; Vitkova M; Rosenberger J; Szilasiova J; Gdovinova Z; Groothoff JW; van Dijk JP
    Disabil Rehabil; 2014; 36(9):732-6. PubMed ID: 23826881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
    Montel SR; Bungener C
    Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study.
    Morales-Gonzáles JM; Benito-León J; Rivera-Navarro J; Mitchell AJ;
    Mult Scler; 2004 Feb; 10(1):47-54. PubMed ID: 14760952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
    Pilutti LA; Dlugonski D; Sandroff BM; Klaren R; Motl RW
    Mult Scler; 2014 Apr; 20(5):594-601. PubMed ID: 24009162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
    Tan-Kristanto S; Kiropoulos LA
    Psychol Health Med; 2015; 20(6):635-45. PubMed ID: 25588098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.
    Kroencke DC; Lynch SG; Denney DR
    Mult Scler; 2000 Apr; 6(2):131-6. PubMed ID: 10773860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of coping strategies in multiple sclerosis: Association with demographic and disease-related characteristics
    Holland DP; Schlüter DK; Young CA; Mills RJ; Rog DJ; Ford HL; Orchard K;
    Mult Scler Relat Disord; 2019 Jan; 27():214-222. PubMed ID: 30412819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.
    Grytten N; Skår AB; Aarseth JH; Assmus J; Farbu E; Lode K; Nyland HI; Smedal T; Myhr KM
    Mult Scler; 2017 Jun; 23(7):1008-1017. PubMed ID: 27600114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding multiple sclerosis fatigue: a synthesis of biological and psychological factors.
    van Kessel K; Moss-Morris R
    J Psychosom Res; 2006 Nov; 61(5):583-5. PubMed ID: 17084134
    [No Abstract]   [Full Text] [Related]  

  • 19. Personality as a predictor of coping efforts in patients with multiple sclerosis.
    Rätsep T; Kallasmaa T; Pulver A; Gross-Paju K
    Mult Scler; 2000 Dec; 6(6):397-402. PubMed ID: 11212136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural relations of illness perception, fatigue, locus of control, self-efficacy, and coping strategies in patients with multiple sclerosis: a cross-sectional study.
    Akbari Esfahani A; Pourshahbaz A; Dolatshahi B
    BMC Public Health; 2024 May; 24(1):1354. PubMed ID: 38769476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.